An 8-Week Refractory Chronic Cough Study (MK-7264-021)
Clinical trial NCT02612623 · COMPLETED
Trial details
- NCT number
- NCT02612623
- Sponsor
- Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-17
- Primary completion
- 2016-05-04
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.